Global merger and acquisition (M&A) activity across the companion and non-companion animal sector experienced a dramatic structural shift in the first quarter of 2026. According to financial market data compiled by investment banking advisor R.L. Hulett and released via GlobalPETS, total transaction volume plummeted 52% year-over-year, falling from 152 reported transactions in Q1 2025 to just 73 deals in Q1 2026.
However, despite the steep drop in raw deal count, the aggregate value of announced transactions surged by 350%, rising from $0.2 billion (€0.17 billion) in Q1 2025 to $0.9 billion (€0.77 billion) in Q1 2026. This marked divergence highlights a transition away from the post-pandemic deal-making sprint toward a market focused on institutional capital deployment in scaled, premium assets.
Geographic Distribution
Europe maintained its position as the world’s most active regional market for pet industry consolidation in Q1 2026, accounting for over four out of every ten completed transactions.
European dominance was driven by sustained cross-border buy-and-build strategies across premium nutrition, private label manufacturing, and digital retail integration. Meanwhile, the United States accounted for 27.4% of global volume, reflecting a temporary pause as institutional sponsors navigated higher interest rate environments before re-entering mid-market buyouts.
Sector Breakdown: Pet Products Retain Dominance as Veterinary Consolidation Plateaus
1. Pet Products (37 Deals | 50.7%)
Pet consumables, food, treats, and accessories continued to capture the majority of M&A flow. Strategic buyers prioritized target companies offering distinct product innovations—particularly in the fresh, raw frozen, freeze-dried, and functional wellness categories. High-profile strategic acquisitions, such as Agrolimen’s purchase of fresh dog food leader Ollie and Pure Treats’ buyout of Primal Pet Foods, underscored the strong appetite for high-margin consumables.
2. Pet & Animal Services (17 Deals | 23.3%)
Pet services—including tech-enabled grooming, premium boarding, canine social clubs, and direct-to-consumer health applications—represented nearly a quarter of all transactions. Driven by return-to-office mandates and urban pet population density, services represent a highly fragmented market with low penetration by corporate entities, making them prime targets for franchised and corporate platform rollups.
3. Veterinary Care Services (6 Deals | 8.1%)
In a stark contrast to the peak consolidation era of 2021–2024, veterinary M&A slowed significantly to record just 6 deals worldwide in Q1 2026. Industry analysts point to a multi-year consolidation plateau: corporate consolidators (such as Mars VCA, VetPartners, and National Veterinary Associates) have slowed clinic acquisitions to integrate existing networks, deal with labor cost inflation, and optimize earnings before pursuing secondary expansion.
Valuation Multiples & Private Equity Dynamics
The sharp surge in overall dollar value alongside declining transaction counts indicates a rebound in enterprise valuation multiples following a three-year period of severe multiple compression.
-
Valuation Rebound: According to investment banking analysis from Cascadia Capital, EV/EBITDA valuation multiples in the pet care sector are reverting toward long-term historical averages (rising to an average 12.1x EV/EBITDA in early 2026 from 11.4x in 2025).
-
Private Equity Selectivity: Private equity sponsors hold significant dry powder but are applying stricter underwriting criteria. Investors are avoiding underperforming assets with high customer acquisition costs, choosing instead to pay premium valuations for established platforms with clear pathways to cost synergies and predictable cash flow.
-
Strategic Buyer Consolidation: Major consumer packaged goods (CPG) players and category leaders are leaning into “buy-versus-build” strategies to gain scale, proprietary manufacturing capacity, and established distribution channels.
Macroeconomic Outlook & Strategic Takeaways
Industry financial advisors, including R.L. Hulett and Cascadia Capital, maintain a constructivist outlook for the remainder of 2026. As central banks ease monetary policy and consumer price sensitivity stabilizes, transaction volume is projected to gradually recover throughout H2 2026.
Sponsors holding aging assets (held 5+ years) are expected to capitalized on rising valuation multiples through target sales or initial public offerings (IPOs), signaling a broader liquidity revival for the companion animal industry.
Data Sources & References
-
R.L. Hulett Investment Banking. (2026, August). Global Pet Industry M&A Report: Q1 2026 Transaction Analytics & Valuation Trends.
-
GlobalPETS / PETS International. (2026, August 25). Pet M&A Deals Slow, But Stronger Valuations Could Revive Activity.
-
Cascadia Capital. (2026, July). Pet Industry Insights – Summer 2026 Report.
